Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR, a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.   13 March 2017
Americas
Pharmaceutical company Neos Therapeutics has entered into a licence agreement with Shire under which Neos has been granted a non-exclusive licence to certain patents.   13 March 2017
Americas
Law firm Perkins Coie has appointed James Hill as a partner in the IP practice in the life sciences industry group.   10 March 2017
Americas
The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.   10 March 2017
Americas
The Patent Trial and Appeal Board upheld Acorda Therapeutics’ patents covering the drug Ampyra in a case against Kyle Bass’s Coalition for Affordable Drugs in a decision handed down yesterday.   10 March 2017
Americas
A jury at the US District Court for the District of Delaware has decided that medical technologies company C R Bard has not infringed a patent owned by W L Gore Associates, a company specialising in products derived from fluoropolymers.   9 March 2017
Americas
US-based Vertex Pharmaceuticals has agreed to acquire a potential treatment for cystic fibrosis from Concert Pharmaceuticals, also in the US, for $160 million.   9 March 2017
Asia
Bayer has been defeated in a patent battle against India-based drugs companies Alembic Pharmaceuticals and Natco Pharma today.   8 March 2017
Americas
US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug.   8 March 2017
Americas
Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.   7 March 2017